What is McKesson's north american pharmaceutical — other?

McKesson (MCK) reported north american pharmaceutical — other of -$1M in Q1 2026.

How has McKesson's north american pharmaceutical — other changed year-over-year?

McKesson's north american pharmaceutical — other increased by 20.0% year-over-year, from -$1.25M to -$1M.

What does north american pharmaceutical — other mean?

Residual operational expenses or income items within the North American pharmaceutical segment that do not fit into primary reporting categories. This captures miscellaneous adjustments, minor operational variances, or non-recurring items specific to the segment's performance.

McKesson MCK North American Pharmaceutical — Other

Other segment segments

Medical-Surgical Solutions

$500K—

Oncology & Multispecialty

$0—

Prescription Technology Solutions

$0—

Similar metrics at other companies

INGMNorth America — Other segment items

-$7.4M+67.4%

KFYNorth America — Other segment items

-$2.41M—

JEL

JELDNorth America — Other segment items

-$18.58M+7.6%

PACKNorth America — Other segment items

-$1.2M+20.0%

AEBINorth America — Other segment items

-$6.03M-237%

LKQNorth America Segment — Other segment items

-$1M+75.0%

Other financials

Income statement

See full

Revenue$96.3B+6.0%

Gross profit$4.0B+11.1%

Operating income$2.2B+35.1%

Net income$1.7B+33.5%

EPS (diluted)$13.65+37.6%

Balance sheet

See full

Cash & equivalents$4.0B-33.3%

Total debt$2.3B-74.2%

Total equity-$2.2B-4.7%

Total assets$82.3B+9.6%

Cash flow

See full

Operating cash flow$3.4B-55.8%

CapEx$111.0M-34.3%

Free cash flow$3.3B-56.3%

Valuation

See full

Market cap$101.33B+17.0%

Enterprise value$99.63B+4.7%

P/E21.3×-6.1×

P/S0.3×0.0×

Profitability

See full

Gross margin3.6%-0.1pp

Operating margin1.5%+0.3pp

Net margin1.2%+0.3pp

FCF margin1.4%-0.1pp

Returns & leverage

See full

Return on equity36%—

Debt / equity2×—

Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:RestructuringReserveTranslationAndOtherAdjustment.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's north american pharmaceutical — other.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is McKesson's north american pharmaceutical — other?: McKesson (MCK) reported north american pharmaceutical — other of -$1M in Q1 2026.
How has McKesson's north american pharmaceutical — other changed year-over-year?: McKesson's north american pharmaceutical — other increased by 20.0% year-over-year, from -$1.25M to -$1M.
What does north american pharmaceutical — other mean?: Residual operational expenses or income items within the North American pharmaceutical segment that do not fit into primary reporting categories. This captures miscellaneous adjustments, minor operational variances, or non-recurring items specific to the segment's performance.